Excellence, Exemplified

At Indago, we’re proud to have earned a reputation for excellence. With numerous awards and hundreds of clinical trials successfully completed to date, we’ve built a reputation for delivering more. More, because we know more reliable data leads to more real lives changed.

When you conduct hundreds of trials with higher standards, the awards and accolades speak for themselves.

Trusted by the Industry’s Leading Sponsors and CROs

The nation’s leading sponsors and CRO’s trust us because they know our commitment to excellence leads to higher enrollment, more reliable data, and a better overall experience for everyone.

Trusted by the Industry’s Leading Sponsors and CROs

The nation’s leading sponsors and CRO’s trust us because they know our commitment to excellence leads to higher enrollment, more reliable data, and a better overall experience for everyone.

Across all Therapeutic areas, our Top Collaborators include:

Volunteer Testimonials

At Indago, we're driven by a simple truth: better trials lead to bigger breakthroughs. But our commitment to excellence isn't just about numbers – it's about the real lives we impact.

Hear directly from the volunteers and participants who have experienced the Indago difference.

Industry Leadership

We are active members of recognized clinical research and site network organizations, and regularly participate in conferences and collaborative events around the country.

Industry Leadership

We are active members of recognized clinical research and site network organizations, and regularly participate in conferences and collaborative events around the country.

Investigator Recognitions

Our investigators are recognized industry leaders, but they never settle. Through ongoing participation in medical conferences, clinical research, and industry events, they continually advance their expertise. Their accomplishments, publications, and contributions reflect a deep commitment not only to scientific excellence but to the communities they serve.

Safety, tolerability, pharmacodynamics and pharmacokinetics of the soluble guanylyl cyclase activator BI 685509 in patients with diabetic kidney disease: A randomized trial

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

Partner with Indago

Ready to experience better clinical trials and bigger breakthroughs? Partner with Indago to experience the excellence that sets us apart. Contact us and see how together, we can fuel the future of healthcare.

CONTACT US

Partner with Indago

Ready to experience better clinical trials and bigger breakthroughs? Partner with Indago to experience the excellence that sets us apart. Contact us and see how together, we can fuel the future of healthcare.

CONTACT US

Privacy Policy | @2026 Copyright by Indago Research and Health Center.